Literature DB >> 33009876

Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: A single-institute experience of 10 cases.

Yoon Ah Cho1, Yoon-La Choi1, Inwoo Hwang1, Kyungjong Lee2, Jong Ho Cho3, Joungho Han1.   

Abstract

BACKGROUND: Nuclear protein in testis (NUT) carcinoma is a rare tumor associated with NUT rearrangement that can present as poorly differentiated to undifferentiated carcinoma, with or without abrupt squamous differentiation. It is often misdiagnosed as poorly differentiated carcinoma or undifferentiated carcinoma if NUT is not suspected. In this study, we retrospectively analyzed pulmonary NUT carcinoma cases diagnosed with NUT immunohistochemical staining and discuss the differential diagnosis to provide information for this rare and aggressive entity.
METHODS: Cases, diagnosed as "NUT carcinoma" in lung pleura and "metastatic NUT carcinoma from the lung" in lymph nodes were diagnosed between 2017 and 2019 at the Samsung Medical Center (SMC). Clinical features such as age, sex, treatment and follow-up period, and pathological reports were obtained by reviewing patients' electronic medical records.
RESULTS: A total of 10 NUT carcinoma cases were found in the SMC pathology database. Seven patients were men and six were non-smokers. Tumor cells showed various cellular features such as round, squamoid, and spindle. Some cases had initially been misdiagnosed as spindle cell neoplasm, round cell sarcoma, squamous cell carcinoma and small cell carcinoma. All cases showed diffuse strong nuclear expression of NUT immunohistochemical staining, and some were positive for p63 staining and negative for CD56 staining.
CONCLUSIONS: NUT carcinoma is often misdiagnosed because of its various morphologies. It is important to consider NUT as one of the differential diagnoses when encountering lung biopsy with undifferentiated morphology. KEY POINTS: Due to various morphological features, NUT carcinoma can be misdiagnosed It is important to consider NUT carcinoma when diagnosing a poorly differentiated or undifferentiated tumor.
© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Lung cancer; NUT carcinoma; pathology

Mesh:

Substances:

Year:  2020        PMID: 33009876      PMCID: PMC7606005          DOI: 10.1111/1759-7714.13648

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

Nuclear protein in testis (NUT) carcinoma is a rare tumor associated with NUT rearrangement. , It mostly arises in midline regions of the head, neck, and thorax but various organs, including the lung, bladder, pancreas, kidney, and salivary glands are affected with a diverse range reported in both age and sex of patients. , , NUT carcinoma is a very aggressive disease, patients usually present at an advanced stage, and it is refractory to conventional chemotherapy with an estimated 9% of patients with progression‐free survival of only two years. , , Histologically, NUT carcinoma presents as poorly differentiated to undifferentiated carcinoma with or without abrupt squamous differentiation, which shows polygonal cells with eosinophilic cytoplasm and keratinization. , , , The tumor cells are usually composed of monomorphic and primitive‐appearing tumor cells. The undifferentiated feature of NUT carcinoma leads to various differential diagnoses, including poorly differentiated non‐small cell carcinoma, small cell lung carcinoma, round cell sarcoma, and high grade lymphoma. As a result, it is often misdiagnosed as poorly differentiated carcinoma or undifferentiated carcinoma if NUT is not suspected. , , , A diagnosis of NUT carcinoma can be made using immunohistochemical staining for NUT protein, which shows 99% negative predictive value and a positive predictive value of 100%. , Previous studies have suggested a bromodomain inhibitor can be used as a target inhibitor of BRD‐NUT fusion. , Approximately 70% of NUT carcinoma cases are associated with BRD4NUT fusion and in the remaining 30%, NUT has been previously reported to fuse with BRD3 or other unknown genes. , In this study, we retrospectively analyzed patients with pulmonary NUT carcinoma diagnosed by NUT immunohistochemical staining and discuss the differential diagnosis to provide information for this rare and aggressive entity.

Methods

Case selection

Cases diagnosed as “NUT carcinoma” in lung pleura and “metastatic NUT carcinoma from the lung” in lymph nodes between 2017 and 2019 were identified through the pathology database at the Samsung Medical Center, Seoul, Republic of Korea. Ultimately, 10 cases were included in the study. Also consecutive 10 cases of poorly differentiated squamous cell carcinoma (SCC), pleomorphic SCC and small cell carcinoma (SmCC) were reviewed for histological comparison. Clinical features such as age, sex, treatment and follow‐up period, and pathological reports were obtained by review of patients; electronic medical records. Two independent pathologists (YAC and JHH) reviewed all hematoxylin and eosin (H&E)‐stained slides for pathological features including histological morphology, keratinization, lymphovascular invasion, necrosis, and mitosis. Immunohistochemistry (IHC) slides and gross photographs were also reviewed. This study was approved by the Institutional Review Board of Samsung Medical Center (2020‐04‐124) and informed consent was waived.

Immunohistochemical staining, interpretation and fluorescence in situ hybridization assay

We used 5 μM formalin‐fixed, paraffin‐embedded tissue sections which were deparaffinized and rehydrated with a xylene and alcohol solution. Immunohistochemical staining was performed using the BOND‐MAX autoimmunostainer (Leica Biosystems, Melbourne, Australia) according to the manufacturer's protocol. Sections underwent antigen retrieval with ER2 buffer (pH 8.0) for 20 minutes at 97°C. After treatment with endogenous peroxidase blocking for 10 minutes, sections were incubated with NUT antibody (C52B1, 1:50, Cell Signaling Technology, Danvers, Massachusetts) for 15 minutes, and Bond Polymer Refine Detection (DS9800, Leica Biosystems, Melbourne, Australia) as a secondary antibody for 10 minutes. IHC slides were interpreted by two independent pathologists (YAC and JHH) as previously described. Antibody against anaplastic lymphoma kinase (ALK) (clone 5A4; 1:30, Novocastra, Newcastle upon Tyne, UK) was used and evaluation of ALK IHC expression was done as previously described. PD‐L1 expression was evaluated using PD‐L1 IHC 22C3 pharmDx assay (Dako, Glostrup, Denmark) as previously described. Two independent pathologists (YAC and JHH) evaluated tumor cells with membranous PD‐L1 staining using tumor proportion scores with cutoff points as previously described. The result of NUT gene (NUTM1) translocation, break‐apart fluorescence in situ hybridization (FISH) was acquired as a generous gift from Dr Yoon Kyung Jeon (Seoul National University).

Results

Clinical characteristics

Clinical characteristics of the cases are summarized in Table 1. A total of seven male and three female patients were included in the study. The median age at diagnosis was 38 years (range, 18–49 years). Six patients were non‐smokers and the others were current or ex‐smokers. All cases presented with lung nodules with or without pleural manifestation. Four patients were diagnosed following routine health examinations, two patients presented with cough, two patients presented with chest pain, one patient presented with right upper quadrant abdominal pain, and the other patient presented with flank pain. The radiological impression of the tumor was non‐small cell lung cancer (nine cases) and malignant tumor (one case). The specimens were obtained from lung, lymph node, and pleural tissues. The majority of the patients were stage III and IV, except for one patient with stage IA (Table 1). With regard to tumor location, they were centrally located in five cases and peripherally in the remainder.
Table 1

Clinical characteristics of 10 nuclear protein in testis (NUT) cases

Case No.AgeSexSpecimenOrganSmoking history (PY)Clinical symptomsStageTumor locationTreatmentFollow‐up
134MBiopsyLungEx‐smoker (7.5)Right upper quadrant abdominal painIVPeripheralGenexol/carboplatin, radiation therapy, pembrolizumabTransferred to another institute
245MBiopsyLymph nodeNon‐smokerIncidental (routine check‐up)IIIACentralAlimta/carboplatin, pembrolizumabComplete response
332MBiopsyLiverEx‐smoker (6)Chest pain, coughIVCentralRefused further treatmentIncreased liver function test, transferred to another institute
438MBiopsyLymph nodeNon‐smokerIncidental (Routine check‐up)IIIACentralPalliative gemcitabine/ cisplatin, pneumonectomy, adjuvant navelbine/cisplatinComplete response
549MMass excisionPleuraNon‐smokerChest painIVPeripheralPalliative vincristine, doxorubicin, tripegfilgrastim and radiationDisease progression, transferred to another institute
641FBiopsyPleuraNon‐smokerFlank painIVPeripherals/p palliative gemcitabine/cisplatinPartial response
744MResectionLungEx‐smoker (10)Incidental (routine check‐up)IIIAPeripheralLobectomy, adjuvant Paclitaxel/carboplatinGamma knife surgery for brain metastasis
848FResectionLungNon‐smokerCough (routine check‐up)IIIACentralNeoadjuvant carboplatin, genexol, pembrolizumab, lobectomy, adjuvant pembolizumabComplete response
943MBiopsyLungCurrent smoker (20)IncidentalIAPeripheralLobectomy with adjuvant paclitaxel/carboplatinComplete response
1018FBiopsyLungNon‐smokerChest painIVCentralPalliative paclitaxel with carboplatinStable disease

PY, pack‐year; s/p, status post.

Clinical characteristics of 10 nuclear protein in testis (NUT) cases PY, pack‐year; s/p, status post. Initial diagnoses of cases included spindle cell neoplasm, (metastatic) SCC, and undifferentiated round cell sarcoma. Except for one patient who refused further treatment and one patient who underwent surgery, the remaining eight patients underwent chemotherapy with different regimens. One patient who had multiple bone and lymph node metastases died one year after diagnosis. The remaining patients survived with four patients transferred to other institutes for further treatment.

Case presentation and pathological findings

Table 2 summarizes the pathological characteristics. Tumor cells showed round, squamoid, and spindle cellular features. Some patients showed overlapping morphological features of tumor cells and about 60% of cases showed squamoid morphology. However, no cases showed keratinization of tumor cells, even in those with predominant squamoid features. The cases showed poorly to undifferentiated features with scant cytoplasm and irregular nuclear contours. One case (10%) showed increased mitotic activity. In addition, three cases showed atypical features, mimicking round cell tumor and undifferentiated tumor features. Three cases (30%) showed fibrotic stroma with separated cell clusters. Coagulative necrosis was observed in four patients (40%). Inflammatory cell infiltration was identified in six patients (60%): two neutrophilic and four lymphocytic infiltration, respectively.
Table 2

Pathological characteristics of 10 nuclear protein in testis (NUT) cases

Case No.Initial diagnosisFinal diagnosisMorphologyNecrosisFibrotic stromaKeratini‐zationInflamm‐atory cellsOther IHC resultsPD‐L1 IHC TPS (%)ALK IHCROS‐1 IHCEGFR status
1Spindle cell neoplasmAtypical cell proliferation, suggestive of NUT carcinomaSpindleNNNNNUT, p63, TTF‐1, CD34, STAT6: +80Wild type
2Metastatic NUT‐midline carcinomaMetastatic NUT‐midline carcinomaRound, squamoidYNNY (neutrophil)

NUT, CK (AE1/AE3), p63: +

TTF‐1, CD56, chromogranin, CD99, CD45: −

70N/A
3Squamous cell carcinomaPoorly differentiated carcinoma, favor NUT carcinomaSquamoidYNNY (neutrophil)

NUT, p63:+

TTF‐1: −

1Wild type
4Metastatic squamous cell carcinoma from lungNUT carcinoma, squamous cell type with pseudoglandular patternSquamoidYYNN

NUT, p63:+

TTF‐1: −

0Wild type
5Undifferentiated round cell sarcoma, FNCLCC grade 3/3NUT carcinomaRoundNYNN

NUT, p53: +

Bcl‐2: Focal +

CK (AE1/AE3): Weak +

p63, CD56, Desmin,Pan TRK, S‐100, Actin (Smooth muscle): −

0Wild type
6Metastatic Squamous cell carcinomaSuggestive of NUT carcinomaSquamoidY (focal)YNY (lymphocyte)NUT: +0Wild type
7Poorly differentiated, non‐small cell carcinoma, consistent with NUT carcinomaPoorly differentiated, non‐small cell carcinoma, consistent with NUT carcinomaRoundYYNY (lymphocyte)

NUT:+

p63, CD56:−

0Wild type
8Metastatic squamous cell carcinomaNUT carcinoma, squamous cell typeSquamoidNNNY (lymphocyte)

NUT, p63:+

CD56:−

0Wild type
9Consistent with NUT carcinomaConsistent with NUT carcinomaSpindle, squamoidNNNY (lymphocyte)NUT, p63:+0N/A
10NUT carcinoma, undifferentiated carcinoma componentNUT carcinoma, undifferentiated carcinoma componentSpindle, roundNNNN

NUT, p63:+

TTF‐1, CD56:−

0N/A

−, negative staining; +, positive staining; ALK, anaplastic lymphoma kinase; CK, cytokeratin; EGFR, epidermal growth factor receptor; FNCLCC, Fédération Nationale des Centres de Lutte le Cancer; N, Absent; N/A, not available; TPS, tumor proportion score; Y, present.

Pathological characteristics of 10 nuclear protein in testis (NUT) cases NUT, CK (AE1/AE3), p63: + TTF‐1, CD56, chromogranin, CD99, CD45: − NUT, p63:+ TTF‐1: − NUT, p63:+ TTF‐1: − NUT, p53: + Bcl‐2: Focal + CK (AE1/AE3): Weak + p63, CD56, Desmin,Pan TRK, S‐100, Actin (Smooth muscle): − NUT:+ p63, CD56:− NUT, p63:+ CD56:− NUT, p63:+ TTF‐1, CD56:− −, negative staining; +, positive staining; ALK, anaplastic lymphoma kinase; CK, cytokeratin; EGFR, epidermal growth factor receptor; FNCLCC, Fédération Nationale des Centres de Lutte le Cancer; N, Absent; N/A, not available; TPS, tumor proportion score; Y, present. Detailed histopathological features of NUT carcinoma were as follows. Case 1 showed spindle cells that could be misdiagnosed as spindle cell neoplasm (Fig 1a,b). Squamous cell carcinoma had been previously diagnosed in three cases. Case 2 and 3 showed squamoid morphology with abundant clear to eosinophilic cytoplasm; however, no definite keratinization was found (Fig 1c,d). Lymphocytic infiltration with abrupt necrosis was found around the tumor cells. In Case 4, most of the cells showed epithelioid features separated by fibrous stroma (Fig 1e); however, abrupt changes to squamoid and dyskeratotic cells with clear cytoplasm were identified. Necrosis was also easily found. Case 8 showed a lobulated growth pattern divided with fibrous stroma. The tumor cells consisted of polygonal cells with scant cytoplasm and inconspicuous nucleoli. Neither necrosis, keratinization, nor abrupt change of dyskeratotic cells were identified. Similar to NUT carcinoma, poorly differentiated SCCs consisted of epithelioid cells, without mature keratinization and were separated by fibrous stroma. Case 5 was initially diagnosed as undifferentiated round cell sarcoma, Fédération Nationale des Centres de Lutte le Cancer (FNCLCC) grade 3/3. Radiological findings suggested pleural malignancy such as sarcoma and mesothelioma due to diffuse pleural infiltration with fluid collection in the right hemithorax and pleural seeding. The tumor showed undifferentiated features with scant cytoplasm, high nuclear to cytoplasmic ratio, and round and spindle morphology (Fig 1f–h). Case 7 showed pleomorphic features (Fig 1i,j). Cells were separated by fibrous stroma and three mitotic figures were found. Pleomorphic features were also found in some SCCs. Similar to NUT carcinomas, there was lymphocytic and neutrophilic infiltration with fibrous stroma. Case 10 showed undifferentiated features with high nuclear to cytoplasmic ratio, inconspicuous nucleoli, and severe crushing artifacts without definite necrosis and mitotic figures (Fig 1k,l). SmCCs also showed similar histological features, such as severe crushing artifacts and scant cytoplasm.
Figure 1

Histological features of representative nuclear protein in testis (NUT) carcinoma. (a, b) NUT carcinoma consists of spindle cells that can be misdiagnosed as spindle cell neoplasm (Case 1). (c) The tumor shows abrupt transition to a squamoid component intermingled with undifferentiated features (Case 2); and (d) may show necrosis (Case 3). (e) Tumors might be separated with fibrous stroma (Case 4). (f–h) The undifferentiated round cells without cytoplasm can mimic round cell sarcoma (Case 5). (i, j) There might be mitotic and pleomorphic features (Case 7); and (k, l) small round tumors with suspicious nuclear molding and inconspicuous nucleoli for neuroendocrine tumors (Case 10).

Histological features of representative nuclear protein in testis (NUT) carcinoma. (a, b) NUT carcinoma consists of spindle cells that can be misdiagnosed as spindle cell neoplasm (Case 1). (c) The tumor shows abrupt transition to a squamoid component intermingled with undifferentiated features (Case 2); and (d) may show necrosis (Case 3). (e) Tumors might be separated with fibrous stroma (Case 4). (f–h) The undifferentiated round cells without cytoplasm can mimic round cell sarcoma (Case 5). (i, j) There might be mitotic and pleomorphic features (Case 7); and (k, l) small round tumors with suspicious nuclear molding and inconspicuous nucleoli for neuroendocrine tumors (Case 10).

Immunohistochemical and fluorescence in situ hybridization findings

All cases showed diffuse strong nuclear expression of NUT. Five cases showed positive p63 IHC staining, with three cases (Cases 3, 4, and 8) showing squamoid features. One case showed TTF‐1 positivity and remaining cases showed negative staining. All cases showed negative staining for CD56. Additional immunostaining was performed in cases with unusual morphology. Case 1, which showed spindle cell morphology, showed positivity for CD34, p63, STAT6, and TTF‐1, with negativity for CK (AE1/AE3). Case 5 showed negativity for desmin, panTrk, CD34, S‐100, CD56, and smooth muscle actin staining and weak positivity for CK(AE1/AE3) staining. Case 10, which presented with spindle to round cell morphology with fine chromatin, was suspicious for neuroendocrine features and diffuse growth patterns. The tumor showed no necrosis and fibrotic stroma. This case showed positivity for p63 and negativity for CD56 staining. The representative immunostaining results are shown in Figure 2. Two cases, showing p63 IHC negativity also showed NUT translocation by fluorescence in situ (FISH) assay (Fig 2). All cases diagnosed as poorly differentiated SCCs, pleomorphic SCCs and SmCCs showed negative staining for NUT IHC.
Figure 2

Immunohistochemical staining of representative nuclear protein in testis (NUT) carcinoma. Case 1 shows positive staining for (a) cytokeratin (AE1/AE3): (b) NUT: and (c) STAT6. Case 3 shows positive staining for (d) NUT; and (e) p63. (f) NUT; and (g) p63 can be positive, as in Case 4. Diffuse NUT staining is shown for (h) Case 5; and (i) Case 7. (k) Case 5 and Case 7 showed NUT translocation confirmed by fluorescence in situ hybridization. Case 10 showed positive (j) NUT; and negative staining for (l) CD56.

Immunohistochemical staining of representative nuclear protein in testis (NUT) carcinoma. Case 1 shows positive staining for (a) cytokeratin (AE1/AE3): (b) NUT: and (c) STAT6. Case 3 shows positive staining for (d) NUT; and (e) p63. (f) NUT; and (g) p63 can be positive, as in Case 4. Diffuse NUT staining is shown for (h) Case 5; and (i) Case 7. (k) Case 5 and Case 7 showed NUT translocation confirmed by fluorescence in situ hybridization. Case 10 showed positive (j) NUT; and negative staining for (l) CD56.

Discussion

Due to various histological features, NUT carcinoma can be misdiagnosed as other tumors when NUT is not suspected. , , , NUT carcinoma can present as entirely undifferentiated carcinoma or present with abrupt transition to squamous differentiation. , , , In this study, four cases were initially diagnosed as squamous cell carcinoma due to evident squamoid morphology; however, in all cases, there was no definite mature keratinization. In previous studies, keratinization is often focal, which can cause sampling bias. , When abrupt keratinization in undifferentiated carcinoma is observed, NUT carcinoma may be suspected. In the present study, six out of 10 cases showed neutrophilic or lymphocytic inflammatory cell infiltration. Inflammatory cell infiltration has also been reported in a previous study. The presence of poorly or undifferentiated tumors in a background of neutrophilic infiltration might suggest the possibility of NUT carcinoma. One case in our study showed spindle cell morphology, with an initial diagnosis of spindle cell neoplasm. In a previous study, various IHC was performed in a patient with NUT carcinoma with spindle cell morphology to rule out spindle cell carcinoma, high grade neuroendocrine tumor, and sarcoma. In our case, CD34 and STAT6 staining was positive, which was suspicious of a solitary fibrous tumor, but the patient presented with a lung mass with aggressive biological behavior. Intraparenchymal solitary fibrous tumors are very rare and usually benign, and not compatible with our case. However, NUT IHC was performed and the patient was finally diagnosed with NUT carcinoma. Further studies are needed to explore whether aberrant expression of CD34 and STAT6 expression in NUT carcinoma is clinically significant. In addition, in the clinical setting of intrapulmonary mass with extensive spindle cells, NUT carcinoma should be also included in the differential diagnosis together with spindle cell carcinoma, pleomorphic carcinoma, and sarcoma. NUT carcinoma can mimic undifferentiated round cell sarcoma, since the tumor may consist of small cells with round nuclei and scant cytoplasm. In four of our cases scant cytoplasm, with round morphology was evident. Although one of the cases mimicked mesothelioma and round cell sarcoma, the immunostaining profile was not indicative of mesothelioma or round cell sarcoma. After intradepartmental discussion, NUT IHC was performed to make a final diagnosis. In addition, round cell morphology with inconspicuous nucleoli and scant cytoplasm might be reminiscent of neuroendocrine tumors, as in Cases 2, 7, 8 and 10; however, CD 56 staining was negative. NUT carcinoma in our study showed poorly to undifferentiated morphology with or without necrosis, and this can mimic various diagnoses. All our cases showed diffuse strong positive staining for NUT immunostaining. In various studies, NUT immunostaining showed 99% negative predictive value and positive predictive value of 100%, , thus immunostaining is useful in daily practice even in patients with various morphologies. Clinically, age of patients ranged from 18 to 49 years old, which is in accordance with previous studies. , , , Patient symptoms included cough, chest pain, and flank pain, which are nonspecific. Four cases diagnosed incidentally on routine health check‐up showed no evidence of disease after operation and adjuvant chemotherapy; however, the remaining patients showed disease progression or no response to chemotherapy and radiation therapy. In conclusion, NUT carcinoma can be a diagnostic challenge due to the various morphologies of the tumor and rarity of the disease. Thus, it is important to consider NUT carcinoma as a differential diagnosis when encountering lung biopsy with undifferentiated morphology.

Disclosure

The authors have no conflicts of interest to declare.
  24 in total

1.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

Authors:  Lynette M Sholl; Mizuki Nishino; Saraswati Pokharel; Mari Mino-Kenudson; Christopher A French; Pasi A Janne; Christopher Lathan
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

2.  Spindle Cell Nuclear in Testis Carcinoma of the Lung: A Challenging Tumor.

Authors:  Giuseppe Pelosi; Maria Cannone; Emanuela Balladore; Daoud Rahal; Paola Bossi; Pierluigi Novellis; Edoardo Bottoni; Luca Toschi; Massimo Roncalli; Christopher A French; Giulia Veronesi
Journal:  J Thorac Oncol       Date:  2018-11-23       Impact factor: 15.609

3.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Authors:  Nicole G Chau; Shelley Hurwitz; Chelsey M Mitchell; Alexandra Aserlind; Noam Grunfeld; Leah Kaplan; Peter Hsi; Daniel E Bauer; Christopher S Lathan; Carlos Rodriguez-Galindo; Roy B Tishler; Robert I Haddad; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Cancer       Date:  2016-08-10       Impact factor: 6.860

4.  Diagnosis of NUT carcinoma of lung origin by next-generation sequencing: case report and review of the literature.

Authors:  Naiquan Mao; Zhiling Liao; Junwei Wu; Kai Liang; Shoufeng Wang; Shaomian Qin; Ying Dou; Hanqing Lin; Xiaowei Dong
Journal:  Cancer Biol Ther       Date:  2018-10-11       Impact factor: 4.742

Review 5.  NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.

Authors:  Christopher A French
Journal:  Pathol Int       Date:  2018-10-26       Impact factor: 2.534

6.  Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review.

Authors:  Shiho Kuroda; Shioto Suzuki; Akira Kurita; Mari Muraki; Yoichiro Aoshima; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Case Rep Pathol       Date:  2015-01-19

7.  Lung nuclear protein in testis carcinoma in an elderly Korean woman: A case report with cytohistological analysis.

Authors:  Hwa Jin Cho; Hyun-Kyung Lee
Journal:  Thorac Cancer       Date:  2020-04-22       Impact factor: 3.500

8.  Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation.

Authors:  Taebum Lee; Sangjoon Choi; Joungho Han; Yoon-La Choi; Kyungjong Lee
Journal:  J Pathol Transl Med       Date:  2018-07-27

Review 9.  Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review.

Authors:  Taebum Lee; Junhun Cho; Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong; Man Ki Chung; Sang Duk Hong; Yong Chan Ahn; Dong Ryul Oh; Jae Myoung Noh; Keunchil Park; Myung-Ju Ahn; Hyung-Jin Kim; Yi Kyung Kim; Young Hyeh Ko
Journal:  Head Neck       Date:  2020-01-06       Impact factor: 3.147

10.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962

View more
  2 in total

1.  Case report: NUT carcinoma in an elderly woman with unique morphology and immunophenotype highlights a diagnostic pitfall.

Authors:  Xuejing Wei; Xiaojing Teng; Yanning Zhang; Ming Cheng; Guangyong Chen
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

Review 2.  NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review.

Authors:  Wenyi Luo; Todd M Stevens; Phillip Stafford; Markku Miettinen; Zoran Gatalica; Semir Vranic
Journal:  Curr Oncol       Date:  2021-11-07       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.